Company: PIII
Filing Date: 2025-02-20
Form Type: PRE 14A
Source: 0001140361-25-005269
Chunk: 21

Company: P3 Health Partners Inc.
Filing Date: 2025-02-20
Form: PRE 14A
Chunk 21
---
 be adjusted as a result of the Reverse Stock Split. In particular, the number of shares issuable upon the exercise of each instrument would be reduced, and the exercise price per share, if applicable, would be increased, in accordance with the terms of each instrument and based on the ratio of the Reverse Stock Split. In addition, the outstanding number of P3 LLC Units held by the Company will also be so proportionately reduced. The chart below outlines the capital structure as described in this proposal and prior to and immediately following a possible Reverse Stock Split if the Reverse Stock Split is effected at a ratio of 1-for-10, 1-for-20, 1-for-30, 1-for-40, 1-for-50, or 1-for-60 based on share information as of the close of business on January 31, 2025, but does not give effect to any other changes, including any issuance of securities after January 31, 2025.

|                                                           |     |      Number of 
      shares of 
   common stock 
 before Reverse 
    Stock Split |     |    1-for-10 |     |    1-for-20 |     |    1-for-30 |     |    1-for-40 |     |    1-for-50 |     |    1-for-60 |
| Class A Authorized                                        |     |    800,000,000 |     | 800,000,000 |     | 800,000,000 |     | 800,000,000 |     | 800,000,000 |     | 800,000,000 |     | 800,000,000 |
| Class V Authorized                                        |     |    205,000,000 |     | 205,000,000 |     | 205,000,000 |     | 205,000,000 |     | 205,000,000 |     | 205,000,000 |     | 205,000,000 |
| Class A Issued and Outstanding                            |     |    162,869,548 |     |  16,286,955 |     |   8,143,477 |     |   5,428,985 |     |   4,071,739 |     |   3,257,391 |     |   2,714,492 |
| Class V Issued and Outstanding                            |     |    195,956